Clinical trial
Study on Amino Acid Uptake in Brain Tumors
NCT00204295 · University Hospital Muenster, Other · Unknown status
Key facts
| NCT number | NCT00204295 |
|---|---|
| Title | Study on Amino Acid Uptake in Brain Tumors |
| Official title | Phase 2 Study on Brain Tumor Uptake of the Amino Acid O-(2-[F-18]Fluorethyl)-L-Tyrosin (FET) |
| Lead sponsor | University Hospital Muenster, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Brain Neoplasms |
| Intervention type | Drug |
| Interventions | O-(2-[F-18]Fluorethyl)-L-Tyrosin (FET) - PET |
| Enrollment | 60 |
| Start date | Jan 1, 2004 |
| First posted | Sep 20, 2005 |
| Last update posted | Sep 14, 2006 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: